While the patient cohort was not large enough to detect significant changes in clinical outcomes, Patient Global Impression of Change showed a positive trend in patients treated with rHIgM22.
← all excerpts
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia.
1
—
—